Randomized double-blind, placebo-controlled phase I trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) administered to patients with advanced cancer before and after chemotherapy-early results - Basser, R; Clarke, K; Fox, R; Green, M; Cebon, J; Marty, J; Menchaca, D; Tomita, D; Begley, C G (Blood, 1995)